DrugBank Open Data2026Reference DatabaseEN
DrugBank: Metformin - Pharmacological Profile
Zusammenfassung
DRUGBANK PHARMACOLOGICAL PROFILE: Metformin
Drug Class: Biguanide antidiabetic
Category: Endocrine
=== MECHANISM OF ACTION ===
Reduces hepatic glucose production, increases insulin sensitivity in peripheral tissues, delays intestinal glucose absorption. Does not stimulate insulin secretion (no hypoglycemia as monotherapy). Also activates AMPK pathway.
=== INDICATIONS ===
- Type 2 diabetes mellitus (first-line)
- PCOS (off-label)
- Prediabetes/diabetes prevention
=== CONTRAINDICATIONS ===
- e
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
DrugBank Open Data2026
DrugBank: Sitagliptin - Pharmacological Profile
DrugBank Open Data2026
DrugBank: Insulin Glargine - Pharmacological Profile
DrugBank Open Data2026
DrugBank: Empagliflozin - Pharmacological Profile
DrugBank Open Data2026
DrugBank: Metoprolol - Pharmacological Profile
DrugBank Open Data2026
DrugBank: Liraglutide - Pharmacological Profile
Cochrane2024
Cochrane Review: Metformin for preventing the progression of chronic kidney disease
Diabetes Canada2018
Diabetes Canada Chapter 13: Pharmacologic Glycemic Management of Type 2 Diabetes in Adults
DrugBank Open Data2026